Prioritizing Biomaterial Driven Clinical Bioactivity Over Designing Intricacy during Bioprinting of Trabecular Microarchitecture: A Clinician’s Perspective

Bibliographic Details
Main Authors: Sahith Kumar Shetty, Shyam Sundar Santhanakrishnan, Shubha Padurao, Pandareesh Mirazkar Dasharatharao
Format: Article
Language:English
Published: American Chemical Society 2024-03-01
Series:ACS Omega
Online Access:https://doi.org/10.1021/acsomega.3c08112
_version_ 1797257416589443072
author Sahith Kumar Shetty
Shyam Sundar Santhanakrishnan
Shubha Padurao
Pandareesh Mirazkar Dasharatharao
author_facet Sahith Kumar Shetty
Shyam Sundar Santhanakrishnan
Shubha Padurao
Pandareesh Mirazkar Dasharatharao
author_sort Sahith Kumar Shetty
collection DOAJ
first_indexed 2024-04-24T22:37:18Z
format Article
id doaj.art-d62ff39fa495491b8c908c286e7f29de
institution Directory Open Access Journal
issn 2470-1343
language English
last_indexed 2024-04-24T22:37:18Z
publishDate 2024-03-01
publisher American Chemical Society
record_format Article
series ACS Omega
spelling doaj.art-d62ff39fa495491b8c908c286e7f29de2024-03-19T10:12:22ZengAmerican Chemical SocietyACS Omega2470-13432024-03-01911124261243510.1021/acsomega.3c08112Prioritizing Biomaterial Driven Clinical Bioactivity Over Designing Intricacy during Bioprinting of Trabecular Microarchitecture: A Clinician’s PerspectiveSahith Kumar Shetty0Shyam Sundar Santhanakrishnan1Shubha Padurao2Pandareesh Mirazkar Dasharatharao3Department of Oral and Maxillofacial Surgery, JSS Dental College and Hospital, JSS Academy of Higher Education and Research, Mysore, IndiaDepartment of Oral and Maxillofacial Surgery, JSS Dental College and Hospital, JSS Academy of Higher Education and Research, Mysore, IndiaDepartment of Material Science, Mangalagangothri Mangalore University, Konaja, IndiaDepartment of Biochemistry, Adichunchanagiri University, Mandya, Indiahttps://doi.org/10.1021/acsomega.3c08112
spellingShingle Sahith Kumar Shetty
Shyam Sundar Santhanakrishnan
Shubha Padurao
Pandareesh Mirazkar Dasharatharao
Prioritizing Biomaterial Driven Clinical Bioactivity Over Designing Intricacy during Bioprinting of Trabecular Microarchitecture: A Clinician’s Perspective
ACS Omega
title Prioritizing Biomaterial Driven Clinical Bioactivity Over Designing Intricacy during Bioprinting of Trabecular Microarchitecture: A Clinician’s Perspective
title_full Prioritizing Biomaterial Driven Clinical Bioactivity Over Designing Intricacy during Bioprinting of Trabecular Microarchitecture: A Clinician’s Perspective
title_fullStr Prioritizing Biomaterial Driven Clinical Bioactivity Over Designing Intricacy during Bioprinting of Trabecular Microarchitecture: A Clinician’s Perspective
title_full_unstemmed Prioritizing Biomaterial Driven Clinical Bioactivity Over Designing Intricacy during Bioprinting of Trabecular Microarchitecture: A Clinician’s Perspective
title_short Prioritizing Biomaterial Driven Clinical Bioactivity Over Designing Intricacy during Bioprinting of Trabecular Microarchitecture: A Clinician’s Perspective
title_sort prioritizing biomaterial driven clinical bioactivity over designing intricacy during bioprinting of trabecular microarchitecture a clinician s perspective
url https://doi.org/10.1021/acsomega.3c08112
work_keys_str_mv AT sahithkumarshetty prioritizingbiomaterialdrivenclinicalbioactivityoverdesigningintricacyduringbioprintingoftrabecularmicroarchitectureacliniciansperspective
AT shyamsundarsanthanakrishnan prioritizingbiomaterialdrivenclinicalbioactivityoverdesigningintricacyduringbioprintingoftrabecularmicroarchitectureacliniciansperspective
AT shubhapadurao prioritizingbiomaterialdrivenclinicalbioactivityoverdesigningintricacyduringbioprintingoftrabecularmicroarchitectureacliniciansperspective
AT pandareeshmirazkardasharatharao prioritizingbiomaterialdrivenclinicalbioactivityoverdesigningintricacyduringbioprintingoftrabecularmicroarchitectureacliniciansperspective